Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

F. Khan, Michael A Linden, Nicole D Zantek, Gregory M Vercellotti

Research output: Contribution to journal › Letter

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)187-188
Number of pages2
JournalTransfusion Medicine
Volume24
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Pure Red-Cell Aplasia
Boronic Acids
Pyrazines
Blood Group Incompatibility
Hematopoietic Stem Cell Transplantation
Subcutaneous Injections
Antineoplastic Agents
Bortezomib

Cite this

Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation. / Khan, F.; Linden, Michael A; Zantek, Nicole D; Vercellotti, Gregory M.

In: Transfusion Medicine, Vol. 24, No. 3, 01.01.2014, p. 187-188.

Research output: Contribution to journal › Letter

Khan, F, Linden, MA, Zantek, ND & Vercellotti, GM 2014, 'Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation', Transfusion Medicine, vol. 24, no. 3, pp. 187-188. https://doi.org/10.1111/tme.12121
Khan F, Linden MA, Zantek ND, Vercellotti GM. Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation. Transfusion Medicine. 2014 Jan 1;24(3):187-188. https://doi.org/10.1111/tme.12121
Khan, F. ; Linden, Michael A ; Zantek, Nicole D ; Vercellotti, Gregory M. / Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation. In: Transfusion Medicine. 2014 ; Vol. 24, No. 3. pp. 187-188.
@article{35df98ef35094a3e9a4fc70ecfb70979,
title = "Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation",
author = "F. Khan and Linden, {Michael A} and Zantek, {Nicole D} and Vercellotti, {Gregory M}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/tme.12121",
language = "English (US)",
volume = "24",
pages = "187--188",
journal = "Transfusion Medicine",
issn = "0958-7578",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

AU - Khan, F.

AU - Linden, Michael A

AU - Zantek, Nicole D

AU - Vercellotti, Gregory M

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84901489095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901489095&partnerID=8YFLogxK

U2 - 10.1111/tme.12121

DO - 10.1111/tme.12121

M3 - Letter

VL - 24

SP - 187

EP - 188

JO - Transfusion Medicine

JF - Transfusion Medicine

SN - 0958-7578

IS - 3

ER -

Access to Document